Daraxonrasib Breakthrough for Pancreatic Cancer | San Jose News

A groundbreaking new drug, Daraxonrasib, is revolutionizing pancreatic cancer treatment by doubling survival rates for advanced patients—earning a standing ovation at a major oncology conference. Patients like 64-year-old Raj Aji, who traveled to San Diego’s Moores Cancer Center for access, are experiencing not just longer lives, but renewed quality of life without chemotherapy’s brutal side effects. Doctors believe this RAS inhibitor could be even more powerful if used earlier in the disease, and the FDA has already approved expanded access for those who don’t qualify for trials. For Raj, the drug has given him time to focus on what truly matters—and opened doors to future hope. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/463ce419deb17a57